These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 19084986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis.
    Fan Y, Liu K, Wang Q, Ruan Y, Zhang Y, Ye W.
    Mol Vis; 2014; 20():1557-68. PubMed ID: 25489228
    [Abstract] [Full Text] [Related]

  • 4. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
    Fan Y, Liu K, Wang Q, Ruan Y, Ye W, Zhang Y.
    Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
    Himeno T, Kamiya H, Naruse K, Harada N, Ozaki N, Seino Y, Shibata T, Kondo M, Kato J, Okawa T, Fukami A, Hamada Y, Inagaki N, Seino Y, Drucker DJ, Oiso Y, Nakamura J.
    Diabetes; 2011 Sep; 60(9):2397-406. PubMed ID: 21810596
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes.
    Mima A, Hiraoka-Yamomoto J, Li Q, Kitada M, Li C, Geraldes P, Matsumoto M, Mizutani K, Park K, Cahill C, Nishikawa S, Rask-Madsen C, King GL.
    Diabetes; 2012 Nov; 61(11):2967-79. PubMed ID: 22826029
    [Abstract] [Full Text] [Related]

  • 14. Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
    Roan JN, Cheng HN, Young CC, Lee CJ, Yeh ML, Luo CY, Tsai YS, Lam CF.
    J Surg Res; 2017 Feb; 208():93-103. PubMed ID: 27993221
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A, Ishibashi Y, Matsui T, Maeda S, Nishino Y, Takeuchi M, Fukami K, Yamagishi S.
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [Abstract] [Full Text] [Related]

  • 17. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H, Gao Y, Zhang J, Wang K, Jin T, Wang H, Ruan K, Wu F, Xu Z.
    J Ethnopharmacol; 2020 Jun 12; 255():112773. PubMed ID: 32199990
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Application of isoproterenol inhibits diabetic-like changes in the rat retina.
    Jiang Y, Walker RJ, Kern TS, Steinle JJ.
    Exp Eye Res; 2010 Aug 12; 91(2):171-9. PubMed ID: 20493839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.